About this trial
The goal of this observational study is to learn about the prevalence of depressive symptoms and cognitive impairment and their association with worse outcomes in a cohort of hospitalized patients between the ages of 18 ang 85 years with chronic heart failure. The main question it aims to answer is:
• Does the presence of depressive symptoms and cognitive impairment lead to worse outcomes in a cohort of hospitalized patients with chronic heart failure? Participants who are hospitalized due to exacerbation of chronic heart failure will answer survey questions to assess their cognitive function and depressive symptoms.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
patient hospitalized primarily for CHF exacerbation;
clinically stable, able to provide informed consent;
do not have severe cognitive impairment that would preclude valid questionnaire administration.
Disqualifiers
hospitalization for acute heart failure;
total length of hospital stay <96 hours;
absence of transthoracic echocardiography (TTE) within the last 12 months and no TTE planned;
severe visual impairment preventing completion of the visual part of the Montreal Cognitive Assessment;
Trial population
Patients hospitalized to the Department of Cardiology and the Internal Medicine Department's Cardiology Profile at the Lithuanian University of Health Sciences Kaunas Hospital, Kaunas, Lithuania
Trial design
Cohort
Prospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
In-hospital all-cause mortality
Lethal all-cause outcome
In-hospital MACE
In-hospital Major Adverse Cardiovascular Event (including myocardial infarction, stroke, cardiovascular death, and need for revascularization \[like repeat PCI or bypass surgery\])
Number of Participants with chronic heart failure-related rehospitalization
Subsequent hospitalization due to chronic heart failure exacerbation (decompensation) within 12 months after the index admission to the hospital (enrollment to the study)
Sponsors and contacts
Click on the lead sponsor to view all of their trials.